Sino Biopharmaceutical Limited (HKG:1177)
8.48
+0.18 (2.17%)
Oct 8, 2025, 2:45 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 148.38 billion as of October 7, 2025. Its market cap has increased by 162.06% in one year.
Market Cap
148.38B
Enterprise Value
153.35B
Revenue
33.49B
Ranking
n/a
PE Ratio
35.18
Stock Price
8.48
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 148.38B, an increase of 44,866.31%. That is a compound annual growth rate of 27.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 6, 2025 | 148.38B | 154.69% |
Dec 31, 2024 | 58.26B | -8.75% |
Dec 29, 2023 | 63.85B | -24.41% |
Dec 30, 2022 | 84.46B | -17.53% |
Dec 31, 2021 | 102.41B | -27.33% |
Dec 31, 2020 | 140.92B | 3.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 295.17B |
Hansoh Pharmaceutical Group Company | 234.53B |
JD Health International | 207.30B |
Innovent Biologics | 172.13B |
WuXi Biologics | 170.68B |
Sichuan Kelun-Biotech Biopharmaceutical | 130.93B |
Akeso | 130.16B |
CSPC Pharmaceutical Group | 110.90B |